Hawkesbury and District General Hospital (HGH) has appointed a new Chief Executive Officer (CEO).
Frédéric Beauchemin will take over as CEO on September 12, succeeding Marc LeBouthillier.
This appointment followed a rigorous consultation and search process launched in March 2022, as HGH completed an important period of development with its redevelopment project around the opening of new medical programs and services.
Beauchemin has close to 25 years of experience in the health care network. He has held various clinical and administrative roles in hospitals, as well as in the private and home care sectors. Since 2019, he has been the Executive Director of Business Development at The Ottawa Hospital, where he was also the Chief of Physiotherapy and Clinical Director of the Rehabilitation Centre, as well as the Neurology, Neurosurgery, Critical Care, Geriatrics, Transitional Care and more than 20 outpatient programs. Previously, Beauchemin was the clinical manager of a complex continuing-care unit at Bruyère.
At the regional and provincial levels, Beauchemin has also played important leadership roles with the Champlain Regional Stroke Network, the Eastern Ontario Regional Geriatric Program, the Champlain Rehabilitation Network and the Ontario Workers Network, as well as serving on various clinical, professional practice and sport committees and boards.
“Given his clinical, operational and business development experience, Mr. Beauchemin is uniquely qualified to continue the growth of the HGH and its drive for excellence. The members of the Board of Directors welcome him and offer him their full cooperation in pursuing the strategic directions adopted to ensure the future of HGH and to make it a model community hospital in Ontario,” said HGH Board of Directors Chair Guy Yelle.
Beauchemin holds a Bachelor of Physical Therapy degree and a Master of Business Administration degree from the University of Ottawa.
